Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 172981, 5 pages
http://dx.doi.org/10.1155/2015/172981
Research Article

Thyroid Peroxidase Antibodies in Non-Interferon Treated Hepatitis C Patients in Pakistan

1Institute of Biochemistry and Biotechnology, University of the Punjab, Lahore 54590, Pakistan
2Institute of Chemistry, University of the Punjab, Lahore 54590, Pakistan
3Department of Biochemistry, SFINHS, Shaikh Zayed Postgraduate Medical Institute, Lahore, Pakistan
4Centre for Nuclear Medicine (CENUM), Mayo Hospital, Lahore 54000, Pakistan

Received 16 July 2015; Accepted 11 October 2015

Academic Editor: Dimitrios P. Bogdanos

Copyright © 2015 Muhammad Imtiaz Shafiq et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Gower, C. Estes, S. Blach, K. Razavi-Shearer, and H. Razavi, “Global epidemiology and genotype distribution of the hepatitis C virus infection,” Journal of Hepatology, vol. 61, no. 1, pp. S45–S57, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. A. G. Khan, M. T. Miller, and J. Marcotrigiano, “HCV glycoprotein structures: what to expect from the unexpected,” Current Opinion in Virology, vol. 12, pp. 53–58, 2015. View at Publisher · View at Google Scholar
  3. F. Penin, J. Dubuisson, F. A. Rey, D. Moradpour, and J.-M. Pawlotsky, “Structural biology of hepatitis C virus,” Hepatology, vol. 39, no. 1, pp. 5–19, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Akeno, J. T. Blackard, and Y. Tomer, “HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity,” Journal of Autoimmunity, vol. 31, no. 4, pp. 339–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Sun, Q. Li, D. Zhu et al., “Enhancement of immune response to a hepatitis C virus E2 DNA vaccine by an immunoglobulin Fc fusion tag,” Journal of Medical Virology, vol. 87, no. 12, pp. 2090–2097, 2015. View at Publisher · View at Google Scholar
  6. A. Antonelli, P. Fallahi, S. M. Ferrari et al., “Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis,” Modern Rheumatology, vol. 22, no. 5, pp. 659–667, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. S. H. Wang, J. D. Bretz, E. Phelps et al., “A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis,” The Journal of Immunology, vol. 168, no. 5, pp. 2470–2474, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Cassani, M. Cataleta, P. Valentini et al., “Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile,” Hepatology, vol. 26, no. 3, pp. 561–566, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Abuaf, F. Lunel, P. Giral et al., “Non-organ specific autoantibodies associated with chronic C virus hepatitis,” Journal of Hepatology, vol. 18, no. 3, pp. 359–364, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Todros, G. Touscoz, N. D'Urso et al., “Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM): clinical characterization from idiopathic LKM-positive disorders,” Journal of Hepatology, vol. 13, no. 1, pp. 128–131, 1991. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Todros, G. Saracco, M. Durazzo et al., “Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes,” Hepatology, vol. 22, no. 5, pp. 1374–1378, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Muratori, M. Lenzi, Y. Ma et al., “Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease,” Gut, vol. 37, no. 3, pp. 406–412, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. Michalska, P. Stalke, K. Witczak-Malinowska et al., “Autoimmune reactions in HBV and HCV,” Medical Science Monitor, vol. 7, pp. 175–180, 2001. View at Google Scholar · View at Scopus
  14. A. Nadeem, M. Aslami, D. A. Khan, T. Hussain, and S. A. Khan, “Effects of combined interferon alpha and ribavirin therapy on thyroid functions in patients with chronic hepatitis C,” Journal of the College of Physicians and Surgeons Pakistan, vol. 19, no. 2, pp. 86–89, 2009. View at Google Scholar · View at Scopus
  15. N. Masood, R. Ghori, A. Memon et al., “Frequency of thyroid disorders during interferon and ribavirin therapy in chronic hepatitis C infection,” Journal of the College of Physicians and Surgeons Pakistan, vol. 18, no. 6, pp. 347–351, 2008. View at Google Scholar · View at Scopus
  16. I. J. Chopra, “A radioimmunoassay for measurement of 3,3′,5′ triiodothyronine (reverse T3),” The Journal of Clinical Investigation, vol. 54, no. 3, pp. 583–592, 1974. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Martino, G. Bambini, L. Bartalena et al., “Human serum thyrotrophin measurement by ultrasensitive immunoradiometric assay as a first-line test in the evaluation of thyroid function,” Clinical Endocrinology, vol. 24, no. 2, pp. 141–148, 1986. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Tran, J.-F. Quaranta, S. Benzaken et al., “High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy,” Hepatology, vol. 18, no. 2, pp. 253–257, 1993. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Zusinaite, K. Metsküla, and R. Salupere, “Autoantibodies and hepatitis C virus genotypes in chronic hepatitis C patients in Estonia,” World Journal of Gastroenterology, vol. 11, no. 4, pp. 488–491, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Yang, Y. Kuang, Y. Liu et al., “Immunogenicity of multiple-epitope antigen gene of HCV carried by novel biodegradable polymers,” Comparative Immunology, Microbiology and Infectious Diseases, vol. 34, no. 1, pp. 65–72, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Antonelli, C. Ferri, P. Fallahi et al., “Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia,” QJM, vol. 97, no. 8, pp. 499–506, 2004. View at Publisher · View at Google Scholar
  22. N. Ganne-Carrie, A. Medini, E. Coderc et al., “Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study,” Journal of Autoimmunity, vol. 14, no. 2, pp. 189–193, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Boadas, J. Rodríguez-Espinosa, J. Enríquez et al., “Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection,” Journal of Hepatology, vol. 22, no. 6, pp. 611–615, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. R. A. Metcalfe, G. Ball, G. Kudesia, and A. P. Weetman, “Failure to find an association between hepatitis C virus and thyroid autoimmunity,” Thyroid, vol. 7, no. 3, pp. 421–424, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Jadali, “Autoimmune thyroid disorders in hepatitis C virus infection: effect of interferon therapy,” Indian Journal of Endocrinology and Metabolism, vol. 17, no. 1, p. 69, 2013. View at Publisher · View at Google Scholar
  26. L. Muratori, D. P. Bogdanos, P. Muratori et al., “Susceptibility to thyroid disorders in hepatitis C,” Clinical Gastroenterology and Hepatology, vol. 3, no. 6, pp. 595–603, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Tomer and A. Huber, “The etiology of autoimmune thyroid disease: a story of genes and environment,” Journal of Autoimmunity, vol. 32, no. 3-4, pp. 231–239, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. C. C. Whitacre, “Sex differences in autoimmune disease,” Nature Immunology, vol. 2, no. 9, pp. 777–780, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Themistoklis, A. Panagiotis, N. Georgios et al., “Thyroid dysfunction and long-term outcome during and after interferon-alpha therapy in patients with chronic hepatitis C,” Annals of the Academy of Medicine, Singapore, vol. 40, no. 9, pp. 394–400, 2011. View at Google Scholar
  30. M.-J. Huang, S.-L. Tsai, B.-Y. Huang, I.-S. Sheen, C.-T. Yeh, and Y.-F. Liaw, “Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study,” Clinical Endocrinology, vol. 50, no. 4, pp. 503–509, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Marazuela, L. García-Buey, B. González-Fernández et al., “Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy,” Clinical Endocrinology, vol. 44, no. 6, pp. 635–642, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Testa, P. Castaldi, V. Fant et al., “Prevalence of HCV antibodies in autoimmune thyroid disease,” European Review for Medical and Pharmacological Sciences, vol. 10, no. 4, pp. 183–186, 2006. View at Google Scholar · View at Scopus
  33. H. G. Hass, R. Klein, O. Nehls, and S. Kaiser, “Thyroid disorders and occurrence of Nonorgan-Specific Autoantibodies (NOSA) in patients with chronic hepatitis C before and during antiviral induction therapy with consensus interferon (interferon alfacon-1),” Journal of Clinical Gastroenterology, vol. 43, no. 5, pp. 470–476, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Nagayama, K. Ohta, M. Tsuruta et al., “Exacerbation of thyroid autoimmunity by interferon α treatment in patients with chronic viral hepatitis: our studies and review of the literature,” Endocrine Journal, vol. 41, no. 5, pp. 565–572, 1994. View at Publisher · View at Google Scholar · View at Scopus